|
Volumn 48, Issue 2, 2005, Pages 81-84
|
Development of novel advanced cell and gene therapy and GMP-controlled cell processing
a a a |
Author keywords
Cell processing; Cell therapy; Development of novel advanced therapy; Gene therapy; Regenerative therapy
|
Indexed keywords
NEW DRUG;
ARTICLE;
BLOOD TRANSFUSION;
CELL TRANSFER;
CELL TRANSPLANTATION;
CLINICAL PRACTICE;
CLINICAL TRIAL;
DRUG APPROVAL;
DRUG INDUSTRY;
DRUG MANUFACTURE;
FOOD AND DRUG ADMINISTRATION;
GENE THERAPY;
GENETIC TRANSDUCTION;
GENETIC TRANSFECTION;
GOOD MANUFACTURING PRACTICE;
HEALTH CARE SYSTEM;
HEMATOPOIETIC STEM CELL TRANSPLANTATION;
HUMAN;
IMMUNOTHERAPY;
JAPAN;
LAW;
MEDICAL ETHICS;
MEDICAL RESEARCH;
REGENERATIVE MEDICINE;
RELIABILITY;
UNITED STATES;
|
EID: 18044361913
PISSN: 13468650
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (5)
|
References (3)
|